SCHEMBL13447791

SCHEMBL13447791

CCCCCO[C@@H]1OC(COC(=O)c2ccccc2)[C@H](OC(=O)c2ccccc2)C(OC(=O)c2ccccc2)C1NC(C)=O

nearest known ligand 0.51

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ LMNA P02545 4/20 0.51
▸ KMT2A Q03164 2/20 0.51
▸ MAPK1 P28482 1/20 0.48
▸ CYP3A4 P08684 1/20 0.47
▸ MAPT P10636 1/20 0.47
▸ CYP2C9 P11712 1/20 0.47
▸ CYP2C19 P33261 1/20 0.47
▸ POLB P06746 3/20 0.47
▸ ALDH1A1 P00352 2/20 0.44
▸ MEN1 O00255 1/20 0.44
▸ USP2 O75604 1/20 0.44
▸ PTPN1 P18031 3/20 0.41
▸ TNF P01375 2/20 0.41
▸ GAPDH P04406 1/20 0.40
▸ KDM4E B2RXH2 1/20 0.39
▸ BMP2 P12643 1/20 0.38
▸ VEGFA P15692 1/20 0.38
▸ CXCL12 P48061 1/20 0.38
▸ SHH Q15465 1/20 0.38
▸ PTPN2 P17706 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL13786400 0.97 LMNA (0.52) LMNAKMT2AMAPK1CYP3A4MAPT
SCHEMBL23763421 0.95 LMNA (0.48) LMNAKMT2AMAPK1CYP3A4MAPT
SCHEMBL14878521 0.92 LMNA (0.50) LMNAKMT2AMAPK1CYP3A4MAPT
SCHEMBL13447797 0.92 LMNA (0.50) LMNAKMT2AMAPK1CYP3A4MAPT
SCHEMBL15592313 0.92 LMNA (0.50) LMNAKMT2AMAPK1CYP3A4MAPT
SCHEMBL24997212 0.92 LMNA (0.50) LMNAKMT2AMAPK1CYP3A4MAPT
SCHEMBL12248448 0.92 LMNA (0.50) LMNAKMT2AMAPK1CYP3A4MAPT
SCHEMBL23394602 0.92 LMNA (0.50) LMNAKMT2AMAPK1CYP3A4MAPT
SCHEMBL13117380 0.92 LMNA (0.50) LMNAKMT2AMAPK1CYP3A4MAPT
SCHEMBL17850335 0.92 LMNA (0.50) LMNAKMT2AMAPK1CYP3A4MAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3034510-A1 OLIGONUCLEOTIDES COMPRISING A C5-MODIFIED PYRIMIDINE Alnylam Pharmaceuticals Inc. (US) 2016-06-22 — — EP disclosed
US-7674778-B2 Oligonucleotides comprising a conjugate group linked through a C5-modified pyrimidine ALNYLAM PHARMACEUTICALS (US) 2010-03-09 — — US disclosed
Send feedback